SALT LAKE CITY, June 28 /PRNewswire-FirstCall/ -- Medical Discoveries, Inc. announced today completion of common stock registration underlying the Series A Convertible Preferred stock and warrants sold in private placements in 2004 and 2005. The agreement was declared effective by the SEC on May 25, 2006.
About Medical Discoveries, Inc.:
Medical Discoveries, Inc. is a developmental- stage bio-pharmaceutical company focused on therapies for major diseases. The Company is leveraging MDI-P, its novel technology that inhibits pathogen production, to generate treatments for Cystic Fibrosis and HIV. MDI recently bolstered its business development program and is pursuing in-licensing opportunities.
This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in MDI’s Form 10-KSB for the year ended December 31, 2005, and in MDI’s periodic reports filed with the Securities and Exchange Commission. MDI is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.
Medical Discoveries, Inc.
CONTACT: Medical Discoveries, Inc., +1-801-582-9583
